Freyr Solutions
Freyr Solutions is a global regulatory solutions and services provider serving pharmaceutical, medical device, and consumer product companies across 120+ countries with 2,500+ in-house experts and an AI-first regulatory cloud platform (Freya Fusion) covering submissions, labeling, and lifecycle management.
- Company typePrivate
- Founded2011
- HeadquartersPrinceton, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Freyr Solutions does
Freyr Solutions is a global regulatory solutions and services company founded in 2011 and headquartered in Princeton, USA, with its primary operational hub in Hyderabad, India. The company serves pharmaceutical, medical device, and consumer product companies across 120+ countries, employing 2,500+ in-house regulatory experts and operating through a network of 850+ in-country regulatory affiliates, 20+ global operational centers, and 10 global delivery hubs. Its core offering is Freya Fusion, an AI-first regulatory cloud platform covering the full regulatory information management (RIM) lifecycle — registrations, submissions, labeling, artwork, intelligence, and change control — complemented by specialized AI products including Freya Intelligence (a regulatory-context-trained knowledge retrieval wizard), Via (an autonomous variation identification agent), and Freyr GRI (an AI/NLP/ML-powered global regulatory intelligence platform).
The company's revenue model combines professional services — regulatory affairs strategy, submissions management, pharmacovigilance, regulatory medical writing, and quality/compliance auditing — with subscription-based SaaS offerings on the Freya Fusion platform. Services are sold via direct enterprise sales to large pharmaceutical, medical device, and consumer product manufacturers under multi-year, quote-based contracts. Customer segments are organized vertically, with pharmaceutical/medicinal products and medical device manufacturers as primary, and cosmetics, food/dietary supplements, and chemical products as secondary verticals. Go-to-market is enterprise-led, supported by inside sales and content marketing (whitepapers, webinars, podcasts, and case studies).
In 2024, Freyr was recognized by Everest Group as a Leader in its PEAK Matrix Assessment for Life Sciences Regulatory and Medical Affairs Operations. The company maintains named executive leadership including Co-Founder and Co-CEO Rajiv Rangan, Co-Founder and Chief Risk Officer Srinivas Ranabothu, Co-Founder Srini Sadhu, and CTO Praveen Bezawada. Ownership is private with no disclosed parent, investor, or funding history in the source material.
Freyr Solutions firmographics
Firmographics- Name
- Freyr Solutions
- Legal name
- Freyr Solutions
- Website
- https://freyrsolutions.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Freyr Solutions is a global regulatory solutions and services provider serving pharmaceutical, medical device, and consumer product companies across 120+ countries with 2,500+ in-house experts and an AI-first regulatory cloud platform (Freya Fusion) covering submissions, labeling, and lifecycle management.
- Ownership category
- akta.pro rank
Freyr Solutions industry classification
Industry- Product category
- Life Sciences Regulatory Services
- NAICS
- Management, Scientific, and Technical Consulting Services (5416)
- SIC
- Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market) (HLAAADAJ)
Keywords
Where Freyr Solutions is headquartered
LocationHeadquarters
- HQ city
- Princeton
- HQ country
- United States
- HQ region
- North America
Offices11 records
Markets served
Freyr Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Regulatory Affairs Services: End-to-end regulatory affairs consulting and support including regulatory strategy, submissions management, dossier authoring, and lifecycle management for pharmaceutical, medical device, and consumer product companies.
- Pharmacovigilance Services: Drug safety monitoring services including medical literature monitoring, individual case safety reports, aggregate safety reports, signal detection, and risk management plans.
- Quality Management and Compliance Services: QMS consultancy, GxP audit services, CSV/CSA services, SOP writing, and regulatory compliance validation for medical devices and pharmaceutical companies.
- Regulatory Technology Solutions: SaaS-based regulatory cloud platform (Freya Fusion) with AI capabilities for submissions management, labeling management, regulatory intelligence, and change control.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on project scope |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
Freyr Solutions product offering
Product offeringCore offering
Freyr Solutions delivers end-to-end regulatory solutions and services for pharmaceutical, medical device, and consumer product companies across 120+ countries. The core offering combines professional services (regulatory affairs, regulatory operations, medical writing, pharmacovigilance, quality/compliance, artwork) with the AI-first Freya Fusion regulatory cloud platform covering RIM, submissions, labeling, artwork, intelligence, and change control. Freyr supports large, medium, and small life sciences firms with 2,500+ in-house regulatory experts and localized affiliate support.
Product overview
Freyr Solutions is the largest global Regulatory solutions and services provider offering end-to-end solutions to the Pharmaceutical (Medicinal Products), Medical Devices, and Consumer sectors. The portfolio consists of the core AI-first technology platform Freya Fusion (unified regulatory cloud covering RIM, submissions, labeling, artwork, intelligence, and change control) supported by specialized sub-products including Freya Intelligence (AI-enabled regulatory advisor with knowledge retrieval), Via (Variation Identification Agent for autonomous post-approval change management), and Freyr GRI (AI/NLP/ML-powered global regulatory intelligence). Services span Regulatory Affairs, Regulatory Operations, Regulatory Medical Writing, Pharmacovigilance, Quality Management, Medical Writing for Medical Devices, Performance Evaluation (IVD), Literature Search Protocol, and Compliance/Audit services across 120+ countries.
Differentiator
Problem solved
Functional benefit
Brands
- Freya Fusion: AI-First Regulatory Cloud - unified regulatory platform designed to manage entire regulatory lifecycle and be the single source of truth for data. Streamlines processes, ensures compliance, and accelerates time-to-market with intelligent automation and connected workflows.
- Freyr GRI
- Freya
- Via (Variation Identification Agent)
Products and services
- Freya Fusion Freya Fusion is an AI-first regulatory cloud platform built on 15+ years of regulatory expertise and advanced AI/ML capabilities. It serves as a unified ecosystem for RIM (Regulatory Information Management), providing a single source of truth for regulatory data across registrations, submissions, labeling, artwork, intelligence, and change control. It is targeted at pharmaceutical, medical device, and consumer product companies seeking a centralized regulatory data backbone.
- Freyr GRI (Global Regulatory Intelligence) Freyr GRI is an AI-powered regulatory intelligence platform that delivers tailored, data-driven insights for regulatory tracking and strategic decision-making. Powered by AI, NLP, and ML technologies, it serves pharmaceutical, medical device, and consumer product companies needing to monitor and interpret regulatory changes across global markets.
- Via - Variation Identification Agent Via is an AI-powered autonomous agent for post-approval change management that identifies variations in regulatory submissions across jurisdictions. It is targeted at pharmaceutical regulatory affairs and operations teams managing complex post-approval change workflows for medicinal products globally.
- Medicinal Products Regulatory Services End-to-end regulatory service offering for pharmaceutical and medicinal product companies covering regulatory affairs strategy, dossier authoring, submissions management, regulatory medical writing, pharmacovigilance, medical and scientific communication, compliance/audit/validation, regulatory artwork, and global regulatory intelligence. It is targeted at innovator and generic pharma companies requiring lifecycle regulatory support across global markets.
- Medical Devices Regulatory Services Comprehensive regulatory service offering for medical device and IVD manufacturers spanning Digital Health/SaMD registration, market access, post-market surveillance, EU MDR/IVDR compliance, clinical and performance evaluation, QMS, artwork services, and regulatory affairs. It is targeted at medical device OEMs, SaMD companies, and IVD manufacturers seeking multi-jurisdictional regulatory support.
- Consumer Sector Regulatory Services Regulatory service offering for consumer product companies in Cosmetics, Food Supplements, and Chemicals. Services include product labeling, safety assessment, global regulatory compliance, formulation review, artwork services, and cosmetovigilance. Targeted at CPG manufacturers expanding into new geographies or responding to evolving regulations such as MoCRA, EUDR, and REACH.
Quantifiable outcome
- Zero rejections achieved for pharmaceutical company managing 15+ ANDAs/NDAs
- +2 more outcomes
Companies that use Freyr Solutions
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles3 records
Freyr Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
Freyr Solutions partnerships and signals
Strategic signalScale indicators6 records
Recent moves5 records
Expansion highlights5 records
Freyr Solutions competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the world's largest CRO and life sciences services firm, offering regulatory affairs and compliance services alongside clinical research, technology, and analytics. It competes with Freyr in pharma regulatory outsourcing and represents the dominant enterprise-scale competitor.
- Parexel International: Parexel is a top-tier global CRO providing regulatory consulting, submissions management, and clinical services to pharma and medical device companies. It overlaps with Freyr's regulatory affairs and medical writing offerings for large pharma clients.
- ICON plc: ICON is a major global CRO with regulatory affairs and pharmacovigilance service lines. After the PRA Health Sciences merger, ICON has substantial regulatory outsourcing capabilities directly comparable to Freyr's service portfolio.
- Labcorp Drug Development (formerly Covance): Labcorp's drug development division offers comprehensive clinical, regulatory, and central lab services to pharma and biopharma. It is a direct competitor in regulatory strategy, submissions, and pharmacovigilance services.
- Accenture Life Sciences: Accenture's Life Sciences practice offers regulatory operations, RIM implementation, and pharmacovigilance consulting leveraging technology and global delivery. It competes directly with Freyr on enterprise RIM and regulatory transformation engagements.
- Deloitte Life Sciences Regulatory: Deloitte's Life Sciences regulatory practice provides regulatory strategy, quality compliance, and technology-enabled regulatory operations consulting. It targets the same large pharma and medical device clients as Freyr with a consulting-led delivery model.
- Charles River Laboratories: Charles River offers regulatory and safety reporting services alongside its core preclinical and clinical lab offerings. It is a relevant peer particularly in pharmacovigilance and safety reporting — directly competing service lines with Freyr.
- Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical, commercial, and regulatory consulting. Its regulatory affairs practice directly overlaps with Freyr's pharma regulatory services.
Direct peers
- Inotiv (regulatory and medical device services): Inotiv (including its Bolt and Boster acquisitions) provides regulatory and medical device consulting services to pharma and medical device clients. It is a more direct niche peer competing in medical device regulatory and quality systems consulting.
- ProPharma Group: ProPharma Group is a regulatory, compliance, and pharmacovigilance consulting firm serving pharma, medical device, and biotech clients. It is one of the most directly comparable specialty regulatory services peers to Freyr in size and service mix.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Freyr Solutions social profiles
Digital presenceFreyr Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Freyr Solutions leadership team
Management profileNumber of profiles
Profiles6 records
Freyr Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Freyr Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Freyr Solutions
What does Freyr Solutions do?
Freyr Solutions delivers end-to-end regulatory solutions and services for pharmaceutical, medical device, and consumer product companies across 120+ countries. The core offering combines professional services (regulatory affairs, regulatory operations, medical writing, pharmacovigilance, quality/compliance, artwork) with the AI-first Freya Fusion regulatory cloud platform covering RIM, submissions, labeling, artwork, intelligence, and change control. Freyr supports large, medium, and small life sciences firms with 2,500+ in-house regulatory experts and localized affiliate support.
Is Freyr Solutions a public or private company?
Freyr Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Freyr Solutions founded?
Freyr Solutions was founded in 2011. It employs 1,001 to 5,000 people.
Where is Freyr Solutions based?
Freyr Solutions is headquartered in Princeton, United States, in the North America region.
How does Freyr Solutions make money?
Four revenue lines are on record. Regulatory Affairs Services are the primary driver. The others are pharmacovigilance Services, quality Management and Compliance Services and regulatory Technology Solutions.
Who are Freyr Solutions's main competitors?
Broad incumbents on record are IQVIA, Parexel International, ICON plc, Labcorp Drug Development (formerly Covance), Accenture Life Sciences, Deloitte Life Sciences Regulatory, Charles River Laboratories and Syneos Health. Direct peers are Inotiv (regulatory and medical device services) and ProPharma Group.
Does Freyr Solutions have an API?
No public API is recorded for Freyr Solutions.
What industry is Freyr Solutions in?
Freyr Solutions's product category is Life Sciences Regulatory Services. Its primary akta.pro industry code is HLAAADAJ, RNA Therapeutics Regulatory, Quality & Pharmacovigilance (GxP, comparability, post-market). Its NAICS code is 5416 and its SIC code is 8700.